The PE Ratio as of September 2024 (TTM) for Legend Biotech Corporation (LEGN) is -34.99

According to Legend Biotech Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -34.99. This represents a change of -38.33% compared to the average of -56.74 of the last 4 quarters.

Legend Biotech Corporation (LEGN) Historical PE Ratio (quarterly & annually)

How has LEGN PE Ratio performed in the past?

The mean historical PE Ratio of Legend Biotech Corporation over the last ten years is -130.06. The current -34.99 PE Ratio has changed 2.59% with respect to the historical average. Over the past ten years (40 quarters), LEGN's PE Ratio was at its highest in in the June 2020 quarter at -8.49. The PE Ratio was at its lowest in in the June 2024 quarter at -115.46.

Legend Biotech Corporation (LEGN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Legend Biotech Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Legend Biotech Corporation (LEGN) Average PE Ratio

How has LEGN PE Ratio performed in the past?

The current PE Ratio of Legend Biotech Corporation (LEGN) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Legend Biotech Corporation (LEGN) PE Ratio vs. Peers

How is LEGN’s PE Ratio compared to its peers?

Legend Biotech Corporation’s PE Ratio is less than Vaxcyte, Inc. (-26.31), less than Apellis Pharmaceuticals, Inc. (-15.28), less than Travere Therapeutics, Inc. (-5.83), less than Akero Therapeutics, Inc. (-8.95), less than IVERIC bio, Inc. (-33.43), less than Blueprint Medicines Corporation (-26.44), less than Amylyx Pharmaceuticals, Inc. (-0.97), less than Karuna Therapeutics, Inc. (-29.52), less than Day One Biopharmaceuticals, Inc. (-7.39), less than Zai Lab Limited (-6.49), greater than Seagen Inc. (-57.36), greater than Alnylam Pharmaceuticals, Inc. (-428.77), less than Ascendis Pharma A/S (-12.57), less than 89bio, Inc. (-4.84), less than Madrigal Pharmaceuticals, Inc. (-10.23), less than Pliant Therapeutics, Inc. (-4.19), greater than Arcellx, Inc. (-70.75), less than Stoke Therapeutics, Inc. (-7.92), less than Mirati Therapeutics, Inc. (-5.32), less than Terns Pharmaceuticals, Inc. (-6.06),

Build a custom stock screener for Legend Biotech Corporation (LEGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Legend Biotech Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Legend Biotech Corporation (LEGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Legend Biotech Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.